109862-53-5Relevant articles and documents
Hybrid materials based on novel 2D lanthanide coordination polymers covalently bonded to amine-modified SBA-15 and MCM-41: assembly, characterization, structural features, thermal and luminescence properties
Wang, Jun,Dou, Wei,Kirillov, Alexander M.,Liu, Weisheng,Xu, Cailing,Fang, Ran,Yang, Lizi
, p. 18610 - 18621 (2016)
Three novel 2D coordination polymers [Tb2(μ4-L)2(μ-HL)(μ-HCOO)(DEF)]n (Tb-L), [Eu(μ4-L)(L)(H2O)2]n (Eu-L), and [Nd(μ4-L)(L)(H2O)2]sub
Rationally designed non-enzymatic fluorogenic 'turn-on' probe for uric acid
Pradhan, Tuhin,Maiti, Sukhendu,Kumar, Rajesh,Lee, Yun Hak,Kim, Jong Wan,Lee, Joung Hae,Kim, Jong Seung
, p. 1 - 6 (2015)
Abstract The simple and cost-effective detection of uric acid in serum or urine is highly desirable as uric acid acts as a biomarker for various diseases. Herein, we report a rationally designed, non-enzymatic probe for the detection of uric acid in serum samples over a wide range of concentrations (lower: ~60 μM, higher: ~700 μM and normal: ~120-380 μM) with 'turn-on' fluorogenic behaviour.
COMPOSITIONS AND METHODS RELATED TO MOLECULAR CONJUGATION
-
Page/Page column 60; 61, (2021/06/11)
The invention relates to activated Michael acceptor (AMA) compounds that can undergo conjugation with biomolecules containing Michael donor moieties, thereby providing plasma-stable antibody-drug conjugates (ADCs). Pharmaceutical compositions of the ADCs are disclosed as well. Also provided herein are a number of applications (e.g., therapeutic applications) in which the compositions are useful.
THERAPEUTIC METHODS
-
Page/Page column 204; 231-232, (2020/05/28)
The invention provides methods and compositions for delivering a nucleic acid to a cell or the cytosol of the target cell. The method includes contacting the cell with, 1) a membrane-destabilizing polymer; and 2) a nucleic acid conjugate. The nucleic acid conjugate includes a targeting ligand bound to an optional linker and a nucleic acid.